The Compendium of Cancer Genome Aberrations: Difference between revisions

[checked revision][checked revision]
No edit summary
No edit summary
Line 1: Line 1:
<br>
<inputbox>
type=search2
break=no
placeholder=enter search term
</inputbox>
[[File:Generic book cover heme and lymphoid.jpg|thumb|link=HAEM5:Table_of_Contents|Search content structured based on the WHO Classification ('''click book image'''). ''Reference: WHO Classification of Tumours Editorial Board. [https://tumourclassification.iarc.who.int/chapters/63 Haematolymphoid tumours] [Internet; beta version ahead of print]. Lyon (France): International Agency for Research on Cancer; 2022. The hierarchical tumour classification structure is reproduced from the [https://tumourclassification.iarc.who.int/welcome/ WHO Classification of Tumours] with permission from the copyright holder, ©International Agency for Research on Cancer.''|alt=]]
<br>
'''Welcome to the Compendium of Cancer Genome Aberrations (CCGA)! The CCGA is a collaborative effort to document and describe clinically relevant chromosomal and other genomic abnormalities in cancer structured based on [https://tumourclassification.iarc.who.int/welcome/ current WHO classification] as published by [https://whobluebooks.iarc.fr/about/ IARC]. The Wiki style interface allows for real-time editing and content sharing within our genetics community. This resource is sponsored and supported by the [http://www.cancergenomics.org <u>Cancer Genomics Consortium (CGC)</u>] and contributed to by colleagues with an interest in clinical cytogenetics, molecular genetics and genomics in cancer.'''
'''Welcome to the Compendium of Cancer Genome Aberrations (CCGA)! The CCGA is a collaborative effort to document and describe clinically relevant chromosomal and other genomic abnormalities in cancer structured based on [https://tumourclassification.iarc.who.int/welcome/ current WHO classification] as published by [https://whobluebooks.iarc.fr/about/ IARC]. The Wiki style interface allows for real-time editing and content sharing within our genetics community. This resource is sponsored and supported by the [http://www.cancergenomics.org <u>Cancer Genomics Consortium (CGC)</u>] and contributed to by colleagues with an interest in clinical cytogenetics, molecular genetics and genomics in cancer.'''


Line 9: Line 18:
*For contributors, we've created a '''<u>[[Video_Tutorial|Video Tutorial]]</u>''' demonstrating how to add content to the CCGA. Please also refer to helpful '''<u>[[Author Instructions|Author Instructions]]</u>'''.
*For contributors, we've created a '''<u>[[Video_Tutorial|Video Tutorial]]</u>''' demonstrating how to add content to the CCGA. Please also refer to helpful '''<u>[[Author Instructions|Author Instructions]]</u>'''.
*Become a part of our Twitter family for the latest updates [https://twitter.com/ccgawiki '''@ccgawiki'''].
*Become a part of our Twitter family for the latest updates [https://twitter.com/ccgawiki '''@ccgawiki'''].
<br>
<inputbox>
type=search2
break=no
placeholder=enter search term
</inputbox>
[[File:Generic book cover heme and lymphoid.jpg|thumb|link=HAEM5:Table_of_Contents|Search content structured based on the WHO Classification ('''click book image'''). ''Reference: WHO Classification of Tumours Editorial Board. [https://tumourclassification.iarc.who.int/chapters/63 Haematolymphoid tumours] [Internet; beta version ahead of print]. Lyon (France): International Agency for Research on Cancer; 2022. The hierarchical tumour classification structure is reproduced from the [https://tumourclassification.iarc.who.int/welcome/ WHO Classification of Tumours] with permission from the copyright holder, ©International Agency for Research on Cancer.''|alt=]]


<br>
 
[[File:CGC logo only.png|100px|link=Main_Page]]<span id="fp-span-cgc-pre"> '''CGC Workgroups Recurrent Loci Tables'''</span><span id="fp-span-cgc" style="display: block; margin-top: -62px; margin-left: 385px;"> [[AML Table: Recurrent Genomic Alterations Detected by Chromosomal Microarray|AML]] | [[MDS, MDS/MPN and MPN Tables: Recurrent Genomic Alterations Detected by Chromosomal Microarray|MDS/MPN]] | [[CLL Tables: Regions of Recurrent Copy Number Change and CN-LOH|CLL]] | [[Recurrent Genomic Alterations in Pediatric and Adult Central Nervous System Tumors Detected by Chromosomal Microarray|CNS Tumors]] | [[Plasma Cell Neoplasms Tables: Recurrent Cytogenomic Alterations|Plasma Cell Neoplasms]] | [[Breast Cancer Table: Recurrent Genomic Alterations Detected by Chromosomal Microarray|Breast Cancer]] | [[Renal Cell Neoplasia Tables: Recurrent Cytogenomic Alterations|Renal Neoplasia]] | [[B-ALL Tables: Prognostic Genomic Abnormalities and Recurrent Gene Fusions|B-ALL]]</span>
[[File:CGC logo only.png|100px|link=Main_Page]]<span id="fp-span-cgc-pre"> '''CGC Workgroups Recurrent Loci Tables'''</span><span id="fp-span-cgc" style="display: block; margin-top: -62px; margin-left: 385px;"> [[AML Table: Recurrent Genomic Alterations Detected by Chromosomal Microarray|AML]] | [[MDS, MDS/MPN and MPN Tables: Recurrent Genomic Alterations Detected by Chromosomal Microarray|MDS/MPN]] | [[CLL Tables: Regions of Recurrent Copy Number Change and CN-LOH|CLL]] | [[Recurrent Genomic Alterations in Pediatric and Adult Central Nervous System Tumors Detected by Chromosomal Microarray|CNS Tumors]] | [[Plasma Cell Neoplasms Tables: Recurrent Cytogenomic Alterations|Plasma Cell Neoplasms]] | [[Breast Cancer Table: Recurrent Genomic Alterations Detected by Chromosomal Microarray|Breast Cancer]] | [[Renal Cell Neoplasia Tables: Recurrent Cytogenomic Alterations|Renal Neoplasia]] | [[B-ALL Tables: Prognostic Genomic Abnormalities and Recurrent Gene Fusions|B-ALL]]</span>
<br>
<br>